Merit Medical Systems, Inc. (NASDAQ:MMSI) Director A Scott Anderson sold 25,000 shares of Merit Medical Systems stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $41.15, for a total transaction of $1,028,750.00. Following the sale, the director now directly owns 10,400 shares in the company, valued at approximately $427,960. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) traded down 1.06% during mid-day trading on Tuesday, reaching $41.95. The company’s stock had a trading volume of 340,924 shares. Merit Medical Systems, Inc. has a 1-year low of $20.70 and a 1-year high of $42.60. The firm’s 50 day moving average price is $38.37 and its 200-day moving average price is $32.44. The company has a market capitalization of $2.10 billion, a price-to-earnings ratio of 59.76 and a beta of 1.26.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Wednesday, July 26th. The medical instruments supplier reported $0.36 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.29 by $0.07. The company had revenue of $186.50 million for the quarter, compared to analyst estimates of $181.46 million. Merit Medical Systems had a net margin of 4.87% and a return on equity of 9.78%. Merit Medical Systems’s revenue for the quarter was up 23.4% on a year-over-year basis. During the same quarter last year, the business earned $0.26 EPS. On average, analysts predict that Merit Medical Systems, Inc. will post $1.26 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This piece was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/08/08/merit-medical-systems-inc-nasdaqmmsi-director-a-scott-anderson-sells-25000-shares.html.

Several analysts have recently commented on the stock. Piper Jaffray Companies reaffirmed a “buy” rating and set a $45.00 price target on shares of Merit Medical Systems in a research report on Friday, July 28th. Craig Hallum reaffirmed a “buy” rating and set a $50.00 price target (up previously from $42.00) on shares of Merit Medical Systems in a research report on Thursday, July 27th. Bank of America Corporation assumed coverage on shares of Merit Medical Systems in a research report on Thursday, July 20th. They set a “buy” rating and a $44.00 price target on the stock. Sidoti reaffirmed a “buy” rating and set a $46.00 price target (up previously from $41.00) on shares of Merit Medical Systems in a research report on Wednesday, June 28th. Finally, BidaskClub raised shares of Merit Medical Systems from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, June 27th. One investment analyst has rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Merit Medical Systems currently has an average rating of “Buy” and a consensus price target of $39.74.

Institutional investors have recently made changes to their positions in the stock. BlackRock Inc. raised its position in shares of Merit Medical Systems by 7,837.9% in the first quarter. BlackRock Inc. now owns 6,789,527 shares of the medical instruments supplier’s stock worth $196,218,000 after buying an additional 6,703,994 shares during the period. Vanguard Group Inc. raised its position in shares of Merit Medical Systems by 16.1% in the first quarter. Vanguard Group Inc. now owns 4,186,883 shares of the medical instruments supplier’s stock worth $121,001,000 after buying an additional 580,871 shares during the period. Frontier Capital Management Co. LLC raised its position in shares of Merit Medical Systems by 24.8% in the second quarter. Frontier Capital Management Co. LLC now owns 2,737,303 shares of the medical instruments supplier’s stock worth $104,428,000 after buying an additional 543,580 shares during the period. Ameriprise Financial Inc. raised its position in shares of Merit Medical Systems by 11.8% in the first quarter. Ameriprise Financial Inc. now owns 1,677,925 shares of the medical instruments supplier’s stock worth $48,491,000 after buying an additional 177,548 shares during the period. Finally, State Street Corp raised its position in shares of Merit Medical Systems by 1.7% in the first quarter. State Street Corp now owns 1,218,788 shares of the medical instruments supplier’s stock worth $35,223,000 after buying an additional 20,885 shares during the period. Institutional investors own 92.11% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.